Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc.
November 03, 2014 10:49 ET
|
Nuvilex, Inc.
SYDNEY, AUSTRALIA--(Marketwired - November 03, 2014) - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be...
Nuvilex, Inc. Engaged in "Cutting Edge" Cannabis Preclinical Studies Using Model Compounds With Cell-in-a-Box
October 29, 2014 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - October 29, 2014) - Nuvilex, Inc. (OTCQB: NVLX) isn't letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its...
Nuvilex Announces Cloning of Cells for Future Phase 3 Clinical Trials Initiated by Inno Biologics
November 04, 2013 09:56 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Nov 4, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases,...
Nuvilex Featured in Recent Forbes and New York Post Articles
October 09, 2013 09:15 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Oct 9, 2013) - Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of...
Nuvilex, Inc. Enters Most Important Step of Phase III Trials Outside of Patient Enrollment
October 01, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 1, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) announced that it had contracted Inno Biologics to generate cell clones that will be the basis of the company's future...
Nuvilex Remains Under Fire While Investors Hold
August 27, 2013 10:10 ET
|
Nuvilex, Inc.
SAN DIEGO, CA--(Marketwired - Aug 27, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, suggests investors consider the agenda when...
Nuvilex, Inc. Strengthens Its Hand in the Cancer Arena With Purchase of Assets
July 30, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 30, 2013) - Nuvilex, Inc. (OTCQB: NVLX) became a much more valuable company in July when it closed a deal it was fully prepared to pay a great deal more money for,...
Nuvilex, Inc. Will Enter Phase III Trials With Advantages Using Cell Encapsulation
July 09, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 9, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) enters its pivotal Phase III clinical trial using its cell encapsulation technology combined with the anti-cancer drug...
Nuvilex, Inc.'s Medical Marijuana Subsidiary Will Be Part of Marijuana Research Boom
June 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 18, 2013) - Nuvilex, Inc.'s (OTCQB: NVLX) subsidiary, Medical Marijuana Sciences, Inc., has already declared its focus will be on pancreatic cancer and cancers...
Nuvilex, Inc.'s Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients
June 06, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 6, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a technology in its cell encapsulation process that will very likely play some role in the future of oncology. How...